It is already well-known that visceral adipose tissue is inseparably related to the
pathogenesis, activity, and general outcome of inflammatory bowel disease (IBD). We are …

Background Sarcopenia, a loss of skeletal muscle mass or function, affects up to 50% of
patients with inflammatory bowel disease (IBD) and is associated with poor clinical …

The incidence of inflammatory bowel disease (IBD) continues to rise worldwide, and patients
with IBD are at increased risk for malnutrition and micronutrient deficiencies. 1 The etiology …

During the disease course, most Inflammatory Bowel Disease patients present a condition of
malnutrition, undernutrition, or even overnutrition. These conditions are mainly due to …

Sarcopenia is a condition marked by progressive loss of skeletal muscle mass and function
while frailty is a multidimensional concept characterized by diminished physiological reserve …

Background: In patients with inflammatory bowel disease (IBD), frailty is independently
associated with mortality and morbidity. Objectives: This study aimed to extend this work to …

Background Sarcopenia is prevalent in patients with inflammatory bowel disease (IBD) and
impacts surgical and therapeutic outcomes; thus, effective diagnostic tools are needed to …

Background This study aimed to determine the prevalence of probable sarcopenia and
sarcopenia in patients with inflammatory bowel disease (IBD) by using the European …

Sarcopenia occurs in patients with Crohn's disease (CD). However, the association between
sarcopenia and loss of response (LOR) to biologic agents remains unclear. This study …

Methods A cross-sectional assessment of sarcopenia in patients with UC was performed.
Disease activity was graded according to complete Mayo score. Hand grip strength was …